Genzyme this week launched its cystic fibrosis gene-sequencing test. The company said the test can detect approximately 98 percent of the more than 1,200 disease-causing mutations in the CFTR gene.
Most genetic CF testing is performed by mutation panels, which detect the most common CFTR mutations. CF gene sequencing detects the most common mutations, as well as less common mutations not included in the available mutation panels.